Patents by Inventor Kevin McIntosh

Kevin McIntosh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Liver stromal cells for prevention and treatment of immune responses in transplantation
    Publication number: 20060057125
    Abstract: The present invention encompasses methods and compositions for reducing an immune response to a transplant in a recipient by treating said recipient with an amount of liver stromal cells effective to reduce or inhibit host rejection of the transplant. Also disclosed is a method of inducing a reduced immune response against a host by foreign tissue, i.e., graft versus host disease, by treatment with liver stromal cells.
    Type: Application
    Filed: September 8, 2005
    Publication date: March 16, 2006
    Inventor: Kevin McIntosh
  • Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation
    Patent number: 6685936
    Abstract: A method of reducing an immune response to a transplant in a recipient by treating said recipient with an amount of suppressor T cells effective to reduce or inhibit host rejection of the transplant. The suppressor T cells can be administered before, at the same time as, or after the transplant. Also disclosed is a method of inducing a reduced immune response against a host by foreign tissue, i.e., graft versus host disease, by treatment with suppressor T cells.
    Type: Grant
    Filed: October 12, 1999
    Date of Patent: February 3, 2004
    Assignee: Osiris Therapeutics, Inc.
    Inventors: Kevin McIntosh, Elena Klyushnenkova
  • SUPPRESSOR CELLS FOR PREVENTION AND TREATMENT OF IMMUNE RESPONSES IN TRANSPLANTATION
    Publication number: 20020034504
    Abstract: A method of reducing an immune response to a transplant in a recipient by treating said recipient with an amount of suppressor T cells effective to reduce or inhibit host rejection of the transplant. The suppressor T cells can be administered before, at the same time as, or after the transplant. Also disclosed is a method of inducing a reduced immune response against a host by foreign tissue, i.e., graft versus host disease, by treatment with suppressor T cells.
    Type: Application
    Filed: October 12, 1999
    Publication date: March 21, 2002
    Inventors: KEVIN MCINTOSH, ELENA KLYUSHNENKOVA
  • Method of preparing suppressor T cells with allogeneic mesenchymal stem cells
    Patent number: 6281012
    Abstract: A method of reducing an immune response to a transplant in a recipient by treating said recipient with an amount of suppressor T cells effective to reduce or inhibit host rejection of the transplant. The suppressor T cells can be administered before, at the same time as, or after the transplant. Also disclosed is a method of inducing a reduced immune response against a host by foreign tissue, i.e., graft versus host disease, by treatment with suppressor T cells.
    Type: Grant
    Filed: May 1, 2000
    Date of Patent: August 28, 2001
    Assignee: Osiris Therapeutics, Inc.
    Inventors: Kevin McIntosh, Elena Klyushnenkova